AADR Among Its Peers
End-of-day Nov 20, 2026 · 1 ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.5% | −10.0% | −10.3% | −14.4% | −16.4% | −13.0% | +45.5% | +18.2% | +95.7% | +232.8% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$50 of every $1,000 in AADR is Banco
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | BBVXFBanco Bilbao Vizcaya | — | 5.04% | $504.14 | 65K | $1.6M |
| 2 | MUFGMitsubishi UFJ Finl | Financial Services | 4.67% | $466.71 | 75K | $1.5M |
| 3 | GMABGenmab A/S | Healthcare | 3.73% | $373.38 | 23K | $1.2M |
| 4 | BCSBarclays -spons | Financial Services | 3.57% | $357.47 | 53K | $1.1M |
| 5 | ARGNFArgenx SE | — | 3.42% | $342.13 | 1,145 | $1.1M |
| 6 | ASNDAscendis Pharma A/S | Healthcare | 3.41% | $340.82 | 4,198 | $1.1M |
| 7 | SMFGSumitomo Mitsui-spons | Financial Services | 3.27% | $326.93 | 46K | $1.0M |
| 8 | TSMTaiwan Semiconductor | Technology | 3.24% | $323.64 | 2,898 | $1.0M |
| 9 | VEONVEON | Communication Services | 3.08% | $308.21 | 13K | $972K |
| 10 | TEVATEVA Pharmaceutical IND | Healthcare | 2.96% | $295.79 | 24K | $933K |
| 11 | NVSNovartis Ag-sponsored | Healthcare | 2.84% | $284.10 | 5,923 | $896K |
| 12 | BAYRYBayer Ag-sponsored | — | 2.84% | $284.02 | 60K | $895K |
| 13 | RYCEFRolls-royce | — | 2.82% | $281.55 | 52K | $888K |
| 14 | CPACopa | Industrials | 2.79% | $278.91 | 6,250 | $879K |
| 15 | EQNREquinor Asa | Energy | 2.75% | $274.87 | 22K | $867K |
AADR has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | BBVXF | Banco Bilbao Vizcaya-sp | 5.04% |
| 2 | MUFG | Mitsubishi UFJ Finl- | 4.67% |
| 3 | GMAB | Genmab A/S -SP | 3.73% |
| 4 | BCS | Barclays -spons | 3.57% |
| 5 | ARGNF | Argenx SE - | 3.42% |
| 6 | ASND | Ascendis Pharma A/S | 3.41% |
| 7 | SMFG | Sumitomo Mitsui-spons | 3.27% |
| 8 | TSM | Taiwan Semiconductor-sp | 3.24% |
| 9 | VEON | VEON | 3.08% |
| 10 | TEVA | TEVA Pharmaceutical IND | 2.96% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| AADR | −0.77 | −1.05 | 21.9% | −25.8% | 1.13 | $110 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 22, 2026 | Sep 29, 2026 | $0.36 |
| Jun 23, 2026 | Jun 29, 2026 | $0.44 |
| Mar 23, 2026 | Mar 30, 2026 | $0.0509 |
| Dec 22, 2025 | Dec 29, 2025 | $0.11 |
| Sep 22, 2025 | Sep 29, 2025 | $0.10 |
| Jun 23, 2025 | Jun 27, 2025 | $0.20 |
| Mar 21, 2025 | Mar 28, 2025 | $0.0168 |
| Sep 23, 2024 | Sep 30, 2024 | $0.37 |
| Jun 24, 2024 | Jun 28, 2024 | $0.53 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0155 |
| Dec 26, 2023 | Dec 29, 2023 | $0.16 |
| Sep 25, 2023 | Sep 29, 2023 | $0.13 |